Month: September 2024

Cayson Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

Written by Customer Service on September 19, 2024. Posted in Public Companies.

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, September 20, 2024, under the ticker symbol “CAPNU.” Each unit consists of one ordinary share and one right entitling its holder to receive one tenth of one ordinary share upon the Company’s completion of an initial business combination, subject to adjustment. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “CAPN” and “CAPNR,” respectively. The Company is a Cayman exempt company, formed as a blank check company for the purpose of entering into...

Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital

Written by Customer Service on September 19, 2024. Posted in Mergers And Acquisitions.

SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC (“Concentra”) to acquire all of the Company’s outstanding shares of common stock for $12.00 per share in cash. As alternative consideration, Concentra stated that it would consider, assuming it receives sufficient interest from existing stockholders, inviting interested stockholders to elect to continue to participate in any future value realized from the Company’s ongoing business by receiving a contingent value right in lieu of receiving $12.00 per share in cash. According to a Schedule 13D filed...

Amaya Big Sky Capital Announces Letter of intent with Flight Food & Beverage Partners for Proposed Qualifying Transaction

Written by Customer Service on September 19, 2024. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ‎‎ Vancouver, BC, Sept. 19, 2024 (GLOBE NEWSWIRE) — Amaya Big Sky Capital Corp. (“Amaya” or the “Company”) (TSX-V: AMYA.P), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “TSX-V”), is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) with Flight Food & Beverage Partners Inc. (“Flight”), an arm’s length party, dated September 17, 2024, in respect of a proposed reverse takeover transaction (the “Transaction”) intended to constitute Amaya’s “qualifying transaction”, as defined under Policy 2.4 of the TSX-V. Upon completion of the Transaction, subject to receipt of all requisite approvals, it is anticipated that the Resulting Issuer (as defined below) will be listed...

Diamondback Energy Announces Launch of Secondary Common Stock Offering

Written by Customer Service on September 19, 2024. Posted in Public Companies.

MIDLAND, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today the launch of an underwritten public offering of 11,270,000 shares of its common stock by certain Legacy Endeavor Stockholders (the “Selling Stockholders”), subject to market and other conditions (the “Secondary Offering”). Diamondback will not receive any proceeds from the sale of the shares by the Selling Stockholders. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,390,500 shares of common stock. In addition, Diamondback has authorized the purchase from the underwriters of 2,000,000 shares of common stock offered in the Secondary Offering (the “Share Repurchase”). The Share Repurchase is part of the Diamondback’s existing share repurchase program....

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.24 Per Share for Q3 2024

Written by Customer Service on September 19, 2024. Posted in Dividend Reports And Estimates.

HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a quarterly distribution of $0.24 per share for the fiscal quarter ended August 31, 2024. This distribution, which is an increase of $0.02 per share over the prior quarter’s distribution, is payable to common stockholders on October 7, 2024 (as outlined in the table below). “We are pleased with KYN’s performance thus far in fiscal 2024 and we are excited to announce this 9% increase to the Company’s distribution,” stated Jim Baker, KYN’s Chairman, President and CEO. “We understand how important distributions are to the Company’s investors, and our goal is to steadily increase KYN’s distribution over time as supported by the Company’s operating results,” continued Mr. Baker.Record Date / Ex-Date Payment Date Distribution...

Battalion Oil Corporation Announces Amendment to Merger Agreement with Fury Resources, Inc.

Written by Customer Service on September 19, 2024. Posted in Mergers And Acquisitions.

Houston, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL) (“Battalion” or the “Company”) announced today that it has entered into an amendment to the previously disclosed Agreement and Plan of Merger (as amended, the “Merger Agreement”) with Fury Resources, Inc. (“Buyer” or “Parent”), pursuant to which Parent has agreed to acquire all of the outstanding shares of Common Stock of the Company (the “Common Stock”) for $7.00 per share in cash, without interest (the “Merger Consideration”). The holders of all of the outstanding shares of the Preferred Stock of the Company, Luminus Management, LLC (“Luminus”), Gen IV Investment Opportunities, LLC, and funds and accounts managed by Oaktree Capital Management, L.P. (“Oaktree”), or their respective affiliates (collectively, the “Rollover Stockholders”),...

Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit

Written by Customer Service on September 19, 2024. Posted in Public Companies.

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate virtually in a fireside chat at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit on Thursday, September 26, 2024, at 8:40 a.m. ET. A live webcast of the presentation can be accessed here or by visiting Events & Presentations in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of the webcast will be available for 60 days on the Company’s website following the conference. About Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is...

Territorial Bancorp Reaffirms Its Board’s Commitment to Proposed Merger with Hope Bancorp

Written by Customer Service on September 19, 2024. Posted in Mergers And Acquisitions.

Rejects Blue Hill Proposal as Highly Uncertain, Inferior to Hope Merger Agreement and Unlikely to Benefit Territorial Shareholders HONOLULU, Sept. 19, 2024 (GLOBE NEWSWIRE) — Territorial Bancorp Inc. (“Territorial”) today reaffirmed the commitment of its Board of Directors to the proposed merger with Hope Bancorp, Inc. (“Hope”) that was announced on April 29, 2024. The announcement was made in response to an unsolicited proposal from Blue Hill Advisors LLC (“Blue Hill”) to acquire Territorial. “The unsolicited letter from Blue Hill claims to provide a nominally higher purchase price, but there are significant factors making the proposal highly uncertain and inferior to the merger agreed upon with Hope,” said Allan S. Kitagawa, Chairman, CEO and President of Territorial. “The Territorial Board carefully considered the proposal on...

Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update

Written by Customer Service on September 19, 2024. Posted in Earnings Releases And Operating Results.

FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to commence in the first half of 2025 REDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs, today reported financial results and provided a business update for the fourth quarter and full fiscal year ended June 30, 2024. “We are thrilled to close out the year with FDA alignment to advance ersodetug in two Phase 3 rare disease programs for the treatment of hypoglycemia resulting from congenital and acquired forms of hyperinsulinism,” said Nevan Elam,...

iPower Reports Fiscal Fourth Quarter and Full Year 2024 Results

Written by Customer Service on September 19, 2024. Posted in Earnings Releases And Operating Results.

Optimization Initiatives Drive Material Gross Margin Expansion and Second Consecutive Quarter of Profitability iPower Management to Host Conference Call Today at 4:30 p.m. Eastern Time RANCHO CUCAMONGA, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven online retailer and supplier of consumer home, pet and garden products, as well as a provider of value-added ecommerce services, today announced its financial results for the fiscal fourth quarter and full fiscal year ended June 30, 2024. Fiscal Q4 2024 Results vs. Year-Ago Quarter Total revenue was $19.5 million compared to $23.4 million. Gross profit increased 2% to $9.2 million, with gross margin up 870 bps to 47.4% compared to 38.7%. Net income attributable to iPower increased to $0.7 million or $0.02 per...

Month: September 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals